Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Gregg

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Neurology|September 1, 1992
Clinical, pathologic, and biochemical features of a cholesterol lipidosis accompanied by hyperlipidemia and xanthomasM R Filling-Katz, S P Miller, H F Merrick, et al.
The American Journal of Cardiology|April 15, 1986
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaJ M Hoeg, M B Maher, L A Zech, et al.
The American Journal of Surgical Pathology|April 1, 1989
Multifocal verruciform xanthoma of the upper aerodigestive tract in a child with a systemic lipid storage diseaseW D Travis, G E Davis, M Tsokos, et al.
Clinical Pharmacology and Therapeutics|October 1, 1984
Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaJ M Hoeg, E J Schaefer, C A Romano, et al.
Circulation|December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacinJ M Hoeg, M B Maher, E Bou, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cellsH Jamil, D A Gordon, D C Eustice, et al.
Journal of Medicinal Chemistry|February 2, 1996
Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moietyJ K Dickson, S A Biller, D R Magnin, et al.
Science (New York, N.Y.)|October 23, 1998
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbitsJ R Wetterau, R E Gregg, T W Harrity, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Neurology|September 1, 1992
Clinical, pathologic, and biochemical features of a cholesterol lipidosis accompanied by hyperlipidemia and xanthomasM R Filling-Katz, S P Miller, H F Merrick, et al.
The American Journal of Cardiology|April 15, 1986
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaJ M Hoeg, M B Maher, L A Zech, et al.
The American Journal of Surgical Pathology|April 1, 1989
Multifocal verruciform xanthoma of the upper aerodigestive tract in a child with a systemic lipid storage diseaseW D Travis, G E Davis, M Tsokos, et al.
Clinical Pharmacology and Therapeutics|October 1, 1984
Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaJ M Hoeg, E J Schaefer, C A Romano, et al.
Circulation|December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacinJ M Hoeg, M B Maher, E Bou, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cellsH Jamil, D A Gordon, D C Eustice, et al.
Journal of Medicinal Chemistry|February 2, 1996
Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moietyJ K Dickson, S A Biller, D R Magnin, et al.
Science (New York, N.Y.)|October 23, 1998
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbitsJ R Wetterau, R E Gregg, T W Harrity, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Pageof 11